Follow
Elicera Therapeutics AB
Nasdaq First North GM (Sweden)
Elicera Therapeutics AB is a clinical stage immuno-oncology company developing cell and gene therapies for immune-based cancer treatments.
Sector:
HEALTH CARE
>
Pharmaceuticals & Biotechnology
 
News
Nothing to display for this company
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
Nasdaq First North GM
Sweden (SE)
Details of share in Elicera Therapeutics AB with ticker
Status
Inactive
Order book id
Amount of instruments
Par value
Currency
SEK
Type
Price
Pre-money
Time
Files
Listing
2021
-
Direct listing of Elicera Therapeutics AB on Nasdaq First North GM
People
Jamal El-Mosleh
CEO
Agneta Edberg
Chairman of the board
Christina Herder
Board member
Jan Zetterberg
Board member
Margareth Jorvid
Board member
Magnus Essand
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Övre Utsiktsvägen 3
Zip code
438 34
City/district
Landvetter
Country
Sweden (SE)
Registration number
556966-4955
LEI code
549300I35L0R4INBFG27
First trade date
Registration date
26 Mar 2014
Short name
Elicera

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More